MyD88-deficiency in macrophages reduced MCP-1 expression and production by LLC cells in vitro, but MyD88-deficiency did not reduce serum MCP-1 levels or LLC tumor volumes as effectively as TNFα-deficiency in vivo. This evidence concerns the gene TNF and neoplasm.